BETHESDA, Md., February 18, 2020 – Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that the 2019 Annual Shareholder’s Meeting will be held on April 18, 2020, at 1:00 pm in Washington, DC.
The Company encourages shareholders to attend what should be an interesting meeting. This announcement is being made to allow shareholders time to make necessary travel plans to come to Washington. The proxy information and other materials will be forwarded to shareholders in an official mailing at a later date.
The Company looks forward to seeing all who can attend.
- DCVAX ® TECHNOLOGY
- PRODUCT CANDIDATES
- CLINICAL TRIALS
- INVESTORS & MEDIA
- ABOUT US